Oxford Biomedical Gets $1.2M Grant To Develop Proteomic Toxicity Screening PanelOxford Biomedical Research Inc., a privately held biotechnology company in Rochester Hills, has been awarded a $1,163,600 Phase 2 Small Business Innovation Research Grant by the National Institute of Environmental Health Sciences.

More From CBS Detroit

Daily J
Valenti and Foster

Watch & Listen